The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
Reads0
Chats0
TLDR
An overview of the cyclic AMP axis and its role as a regulator of immune functions is provided and the clinical and translational relevance of interventions with these processes are discussed.Abstract:
Nucleotide signaling molecules contribute to the regulation of cellular pathways. In the immune system, cyclic adenosine monophosphate (cAMP) is well established as a potent regulator of innate and adaptive immune cell functions. Therapeutic strategies to interrupt or enhance cAMP generation or effects have immunoregulatory potential in autoimmune and inflammatory disorders. Here, we provide an overview of the cyclic AMP axis and its role as a regulator of immune functions and discuss the clinical and translational relevance of interventions with these processes.read more
Citations
More filters
Journal ArticleDOI
Kynurenic Acid: The Janus-Faced Role of an Immunomodulatory Tryptophan Metabolite and Its Link to Pathological Conditions
TL;DR: This review provides a comprehensive update of the significant biological functions of KYNA and focuses on its immunomodulatory properties by signaling via G-protein-coupled receptor 35 (GPR35)- and aryl hydrocarbon receptor-mediated pathways.
Journal ArticleDOI
Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond.
TL;DR: Emerging evidence supports novel strategies to therapeutically target PDE function, including enhancing catalytic activity, normalizing altered compartmentalization and modulating post-translational modifications, as well as the potential use of PDEs as disease biomarkers.
Journal ArticleDOI
Targeting cell signaling in allergic asthma
TL;DR: Therapeutic drugs can be designed to target one or more of these pathways to treat asthma, and the potential molecular pathways that can be targeted include IL-4-IL-13-JAK-STAT-MAP kinases.
Journal ArticleDOI
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways
Bing Huang,Zhanghua Chen,Lanlan Geng,Jun Wang,Huiying Liang,Yujie Cao,Huan Chen,Wanming Huang,Meiling Su,Hanqing Wang,Yanhui Xu,Yukun Liu,Bingtai Lu,Huifang Xian,Huiwen Li,Huilin Li,Lu Ren,Jing Xie,Liping Ye,Hongli Wang,Junhong Zhao,Peiyu Chen,Li Zhang,Shanmeizi Zhao,Zhang Ting,Banglao Xu,Di Che,Wenyue Si,Xiaoqiong Gu,Liang Zeng,Yong Wang,Ding-You Li,Yifan Zhan,David Delfouneso,Andrew M. Lew,Jun Cui,Wai Ho Tang,Yan Zhang,Sitang Gong,Fan Bai,Min Yang,Yuxia Zhang,Yuxia Zhang +42 more
TL;DR: Detailed analysis of the colonic mucosae has uncovered common pathogenesis and therapeutic targets for children with colitis and IBD, and Targeting these pathways by using the phosphodiesterase inhibitor dipyridamole restored immune homeostasis and improved colitis symptoms in a pilot study.
Journal ArticleDOI
Calcitonin Gene-Related Peptide Negatively Regulates Alarmin-Driven Type 2 Innate Lymphoid Cell Responses
Antonia Wallrapp,Patrick R. Burkett,Samantha J. Riesenfeld,Kim Se-Jin,Elena Christian,Elena Christian,Raja-Elie E. Abdulnour,Pratiksha I. Thakore,Alexandra Schnell,Conner Lambden,Conner Lambden,Rebecca H. Herbst,Pavana Khan,Kazutake Tsujikawa,Ramnik J. Xavier,Ramnik J. Xavier,Isaac M. Chiu,Bruce D. Levy,Aviv Regev,Aviv Regev,Vijay K. Kuchroo,Vijay K. Kuchroo +21 more
TL;DR: It is shown that type 2 innate lymphoid cells (ILC2s) expressed both the neuropeptide calcitonin gene-related peptide (CGRP) and its receptor, indicating that endogenous CGRP is a critical negative regulator of ILC2 responses in vivo.
References
More filters
Journal ArticleDOI
What is a randomised controlled trial
Andrea Cipriani,John R. Geddes +1 more
TL;DR: The Consolidated Statement of Reporting Trials (CONSORT) provides readers of RCTs with a list of criteria useful to assess trial validity (for full details visit www.consortstatement.org).
Journal ArticleDOI
Mechanisms of type-I- and type-II-interferon-mediated signalling.
TL;DR: It is anticipated that an increased understanding of the contributions of these recently identified pathways will advance current thinking about how interferons work.
Journal ArticleDOI
Transcriptional regulation by the phosphorylation-dependent factor CREB
Bernhard M. Mayr,Marc Montminy +1 more
TL;DR: The transcription factor CREB functions in glucose homeostasis, growth-factor-dependent cell survival, and has been implicated in learning and memory, and how is specificity achieved in these signalling pathways?
Journal ArticleDOI
FOXP3 + regulatory T cells in the human immune system
Shimon Sakaguchi,Makoto Miyara,Makoto Miyara,Cristina M. Costantino,Cristina M. Costantino,David A. Hafler,David A. Hafler +6 more
TL;DR: Recent findings regarding human TReg cells are discussed, including the ontogeny and development of TReg cell subsets that have naive or memory phenotypes, the unique mechanisms of suppression mediated by TRegcell subsets and factors that regulateTReg cell lineage commitment.
Journal ArticleDOI
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
Silvia Deaglio,Karen M. Dwyer,Wenda Gao,David J. Friedman,Anny Usheva,Anna Erat,Jiang-Fan Chen,Keiichii Enjyoji,Joel Linden,Mohamed Oukka,Vijay K. Kuchroo,Terry B. Strom,Simon C. Robson +12 more
TL;DR: It is concluded that CD39 and CD73 are surface markers of T reg cells that impart a specific biochemical signature characterized by adenosine generation that has functional relevance for cellular immunoregulation.